In prostate cancer, scientists discovered that Trop2 regulate cancer cell proliferation, self-renewal, cell-cell adhesion and metastasis through β-catenin and β1-integrin signaling pathways [77,78,79]. Here, TACSTD2 is linked to prostate carcinoma.